Myomo (MYO) Change in Receivables (2016 - 2025)
Myomo (MYO) posted Change in Receivables of -$1.9 million for Q3 2025, down 179.72% on a QoQ basis from $2.3 million in Q2 2025, and down 283.81% year-over-year from $1.0 million in Q3 2024.
Myomo (MYO) Change in Receivables (2016 - 2025) Analysis & Trends
Myomo's Change in Receivables history runs 10 years deep, the most recent figure standing at -$1.9 million for Q3 2025.
- Quarterly Change in Receivables fell 283.81% year-over-year to -$1.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $1.6 million (up 57.6% YoY) and the FY2024 annual result came in at $1.6 million, up 214.69% from the prior year.
- Change in Receivables was -$1.9 million for Q3 2025 at Myomo, down from $2.3 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.3 million in Q2 2025 and bottomed at -$1.9 million in Q3 2025.
- A 5-year average of $219224.1 and a median of $239274.0 in 2022 frame the typical range for Change in Receivables.
- Annual changes were most pronounced in 2021 — Change in Receivables surged 6143.87% — and 2025, when it slumped 283.81%.
- Myomo's Change in Receivables stood at -$235707.0 in 2021, then soared by 233.77% to $315314.0 in 2022, then tumbled by 141.23% to -$129997.0 in 2023, then surged by 440.97% to $443252.0 in 2024, then sank by 520.54% to -$1.9 million in 2025.
- Business Quant data shows MYO's Change in Receivables at -$1.9 million in Q3 2025, $2.3 million in Q2 2025, and $637054.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Myomo | 39.24 Mn | 20.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1.86 Mn |
| Sep 30, 2025 | -1.86 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Jun 30, 2025 | 2.34 Mn |
| Mar 31, 2025 | 637,054.00 |
| Mar 31, 2025 | 637,054.00 |
| Dec 31, 2024 | 443,252.00 |
| Dec 31, 2024 | 443,252.00 |
| Sep 30, 2024 | 1.01 Mn |
| Sep 30, 2024 | 1.01 Mn |
| Jun 30, 2024 | 820,910.00 |
| Jun 30, 2024 | 820,910.00 |
| Mar 31, 2024 | -718,676.00 |
| Mar 31, 2024 | -718,676.00 |
| Dec 31, 2023 | -129,997.00 |
| Dec 31, 2023 | -129,997.00 |
| Sep 30, 2023 | 861,473.00 |
| Sep 30, 2023 | 861,473.00 |
| Jun 30, 2023 | 104,656.00 |
| Jun 30, 2023 | 104,656.00 |